How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program

Kidney International
Marcello TonelliDonal O'Donoghue


Many countries are developing or refining national strategies for noncommunicable chronic disease (NCD) prevention and control. Chronic kidney disease (CKD) is a cause and consequence of other NCDs; CKD acts as a risk multiplier for all four key NCDs as specified by the World Health Organization; CKD is associated with high health-care costs; CKD is readily identifiable; and treatment of CKD is cost-effective and improves outcomes. These observations argue in favor of including CKD in national NCD programs. The purpose of this article is to outline key steps in advocating for the inclusion of CKD in national NCD strategies.


Nov 16, 2010·Lancet·Robert GeneauRobert Beaglehole
Apr 9, 2011·Lancet·Robert BeagleholeUNKNOWN NCD Alliance
Aug 16, 2011·Lancet·Josefien van OlmenSlim Slama
Oct 14, 2011·Kidney International·William G CouserMarcello Tonelli

❮ Previous
Next ❯


Mar 6, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vivekanand Jha, Narayan Prasad
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Aminu K BelloUNKNOWN Kidney Health for Life Initiative
Nov 24, 2017·Nature Reviews. Disease Primers·Paola RomagnaniHans-Joachim Anders
Dec 12, 2017·BMJ Global Health·Brendon Lange NeuenVlado Perkovic
Sep 25, 2020·BMC Nephrology·Jerry Brown AsenehValirie Ndip Agbor
Dec 18, 2018·Frontiers in Medicine·Narayan Prasad, Manas Ranjan Patel

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.